We are actively seeking additional assets to add to the Inotek’s ophthalmology portfolio. Areas of interest include programs that address serious diseases with unmet medical including: dry-AMD, diabetic macular edema, dry eye, and orphan indications addressing retinal neuropathies and pathologies associated with rapid loss of photoreceptors. Please contact us at: partners@inotekpharma.com.